Government of Canada Improves Access to Affordable and Effective Drugs for Rare Diseases
The Government of Canada has made an announcement which will benefit the 1 in 12 people (many of whom are children) living with a rare disease in the country.
Applications Now Open for the 2023/2024 Creative Destruction Lab Program
Creative Destruction Lab (CDL) has announced that application are open for the 2023/2024 Program Year. This will be CDL's 12th cohort.
BC announces a new Life Sciences and Biomanufacturing Strategy
The Academy of Translational Medicine is excited to hear about the announcement of the Life Sciences and Biomanufacturing Strategy and what it will mean for translational medicine efforts in the province.
Aspect Biosystems and Novo Nordisk Enter Partnership to Develop Bioprinted Tissue Therapeutics for Diabetes and Obesity
This partnership allows Aspect and Novo Nordisk to join the proprietary bioprinting technology from Aspect with the expertise and technology that Novo Nordisk has in stem cell differentiation and cell therapy development and manufacturing.
Applications Open: 2023 Convening & Collaborating (C2) and Reach Programs
Each award offers up to $15,000 for a term of 18 months, targeting knowledge translation (KT) work to help propel research towards use in policy and in practice.
Nominations Open: 2023 Faculty of Medicine Awards
The awards acknowledge outstanding faculty and staff members who demonstrate exceptional contributions to the Faculty of Medicine, and who are dedicated to advancing the Faculty’s values and vision of transforming health for everyone.
Call for Abstracts: Image-Guided Therapeutics Symposium 2023
Sunnybrook Research Institute is hosting the Symposium in Toronto on Monday June 12th, 2023. The deadline for poster and oral abstracts is April 14th, 2023.
Call for Proposals: 2023-2024 Canada-Germany Collaborative Industrial Research and Development (NRC IRAP-ZIM Call 11)
Working together, the Government of Canada and the Government of Germany aim to foster and support collaborative industrial research and development (R&D) projects with high potential for commercialization.
adMare Academy launches BioInnovation Scientist (BIS) Program: Foundations
The BIS Program: Foundations is targeted at scientists residing in Canada who are either newly employed in industry or working/training in academia, with a view to transition to commercial organizations.